The current landscape: Allogeneic hematopoietic stem cell transplant for acute lymphoblastic leukemia
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The current landscape: Allogeneic hematopoietic stem cell transplant for acute lymphoblastic leukemia
Authors
Keywords
-
Journal
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
Volume -, Issue -, Pages 101485
Publisher
Elsevier BV
Online
2023-06-04
DOI
10.1016/j.beha.2023.101485
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fludarabine or cyclophosphamide in combination with total body irradiation as myeloablative conditioning prior to allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the EBMT
- (2023) Sebastian Giebel et al. BONE MARROW TRANSPLANTATION
- T-replete cord transplants give superior outcomes in high risk and relapsed/refractory paediatric myeloid malignancy
- (2023) Claire Horgan et al. Blood Advances
- Total body irradiation versus busulfan based intermediate intensity conditioning for stem cell transplantation in ALL patients >45 years—a registry-based study by the Acute Leukemia Working Party of the EBMT
- (2023) Klaus Hirschbühl et al. BONE MARROW TRANSPLANTATION
- Total body irradiation plus fludarabine versus thiotepa, busulfan plus fludarabine as a myeloablative conditioning for adults with acute lymphoblastic leukemia treated with haploidentical hematopoietic cell transplantation. A study by the Acute Leukemia Working Party of the EBMT
- (2022) Ryszard Swoboda et al. BONE MARROW TRANSPLANTATION
- In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trial
- (2022) David I Marks et al. Lancet Haematology
- A phase 1 study of donor regulatory T-cell infusion plus low-dose interleukin-2 for steroid-refractory chronic graft-vs-host disease
- (2022) Jennifer Whangbo et al. Blood Advances
- KIR-Favorable TCR-αβ/CD19-Depleted Haploidentical HCT in Children with ALL/AML/MDS: Primary Analysis of PTCTC ONC1401
- (2022) Michael A Pulsipher et al. BLOOD
- Should all CAR-T therapy for acute lymphoblastic leukemia Be consolidated with allogeneic stem cell transplant?
- (2022) Alejandro Marinos et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD
- (2021) Benjamin Watkins et al. JOURNAL OF CLINICAL ONCOLOGY
- Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR
- (2021) Matthew J. Wieduwilt et al. LEUKEMIA
- Omidubicel Versus Standard Myeloablative Umbilical Cord Blood Transplantation: Results of a Phase III Randomized Study
- (2021) Mitchell E Horwitz et al. BLOOD
- Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT
- (2021) Jaime Sanz et al. Journal of Hematology & Oncology
- KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study
- (2021) Bijal D Shah et al. LANCET
- Haploidentical vs. sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia
- (2021) Matthew J Wieduwilt et al. Blood Advances
- Clofarabine-fludarabine-busulfan in HCT for pediatric leukemia: an effective, low toxicity, TBI-free conditioning regimen
- (2021) Birgitta Versluijs et al. Blood Advances
- Neoantigens in Hematologic Malignancies
- (2020) Melinda A. Biernacki et al. Frontiers in Immunology
- Treosulfan–fludarabine–thiotepa-based conditioning treatment before allogeneic hematopoietic stem cell transplantation for pediatric patients with hematological malignancies
- (2020) Krzysztof Kalwak et al. BONE MARROW TRANSPLANTATION
- Comparison of reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia >45 years undergoing allogeneic stem cell transplantation—a retrospective study by the Acute Leukemia Working Party of EBMT
- (2020) Zinaida Peric et al. BONE MARROW TRANSPLANTATION
- Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP study
- (2020) Andre Manfred Willasch et al. BONE MARROW TRANSPLANTATION
- Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor Transplantation
- (2020) Effie W. Petersdorf et al. JOURNAL OF CLINICAL ONCOLOGY
- Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study
- (2020) Houli Zhao et al. Journal of Hematology & Oncology
- A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trial
- (2020) Daisuke Tomizawa et al. BLOOD
- Review of conditioning regimens for haplo-identical donor transplants using post-transplant cyclophosphamide in recipients of G-CSF mobilised peripheral stem cell
- (2020) Sushrut Patil et al. CANCER TREATMENT REVIEWS
- Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults
- (2020) Robin Foà et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of prognostic factors in childhood T‐cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05‐001 and 11‐001
- (2020) Melissa A. Burns et al. PEDIATRIC BLOOD & CANCER
- A validated pediatric disease risk index for allogeneic hematopoietic cell transplantation
- (2020) Muna Qayed et al. BLOOD
- High progression-free survival after intermediate intensity double unit cord blood transplantation in adults
- (2020) Juliet N. Barker et al. Blood Advances
- Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Retrospective Multinational Study
- (2019) Ching-Hon Pui et al. JOURNAL OF CLINICAL ONCOLOGY
- Low burden of minimal residual disease prior to transplantation in children with very high risk acute lymphoblastic leukaemia: The NOPHO ALL2008 experience
- (2019) Marianne Ifversen et al. BRITISH JOURNAL OF HAEMATOLOGY
- Total body irradiation dose and risk of subsequent neoplasms following allogeneic hematopoietic cell transplantation
- (2019) K. Scott Baker et al. BLOOD
- Hematopoietic Stem-Cell Transplantation Does Not Improve the Poor Outcome of Children With Hypodiploid Acute Lymphoblastic Leukemia: A Report From Children’s Oncology Group
- (2019) Jennifer L. McNeer et al. JOURNAL OF CLINICAL ONCOLOGY
- Allogeneic Hematopoietic Cell Transplantation in the Outpatient Setting
- (2019) Noa Granot et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study
- (2019) Rob Pieters et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Randomized Study Comparing Myeloablative Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Stem Cell Transplantation for Adults with Hematologic Malignancies
- (2019) Jaime Sanz et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study
- (2019) Effie W Petersdorf et al. Lancet Haematology
- Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia
- (2018) Partow Kebriaei et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
- (2018) Jae H. Park et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcomes After Second Hematopoietic Cell Transplant for Children and Young Adults with Relapsed Acute Leukemia
- (2018) Troy C. Lund et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Influence of pre-transplant minimal residual disease on prognosis after Allo-SCT for patients with acute lymphoblastic leukemia: systematic review and meta-analysis
- (2018) Zhenglei Shen et al. BMC CANCER
- Long-term Effects of Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Lymphoblastic Leukemia
- (2018) Anita Lawitschka et al. Current Oncology Reports
- Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome–Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter Study
- (2017) Giovanni Martinelli et al. JOURNAL OF CLINICAL ONCOLOGY
- Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
- (2017) Hagop Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: a survey from the acute leukemia working party of EBMT
- (2017) Gabrielle Roth-Guepin et al. Oncotarget
- Mechanistic approaches for the prevention and treatment of chronic GVHD
- (2016) Corey S. Cutler et al. BLOOD
- Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome–positive ALL
- (2016) Philippe Rousselot et al. BLOOD
- Incidence and severity of crucial late effects after allogeneic HSCT for malignancy under the age of 3 years: TBI is what really matters
- (2016) D Bresters et al. BONE MARROW TRANSPLANTATION
- Nonmyeloablative allogeneic hematopoietic cell transplantation
- (2016) R. Storb et al. HAEMATOLOGICA
- TcRαβ-depleted haploidentical transplantation results in adult acute leukemia patients
- (2016) Leylagul Kaynar et al. Hematology
- Cord-Blood Transplantation in Patients with Minimal Residual Disease
- (2016) Filippo Milano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia
- (2016) Hagop M. Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nonmyeloablative allogeneic hematopoietic cell transplantation
- (2016) R. Storb et al. HAEMATOLOGICA
- Transplant Outcomes for Children with T Cell Acute Lymphoblastic Leukemia in Second Remission: A Report from the Center for International Blood and Marrow Transplant Research
- (2015) Michael J. Burke et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Significant Improvement in Survival after Unrelated Donor Hematopoietic Cell Transplantation in the Recent Era
- (2015) Navneet S. Majhail et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study
- (2015) Mohamed L. Sorror et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients
- (2015) M. A. Pulsipher et al. BLOOD
- Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia
- (2015) N. Dhedin et al. BLOOD
- Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT
- (2015) X Cahu et al. BONE MARROW TRANSPLANTATION
- Allogeneic stem cell transplantation after conditioning with treosulfan, etoposide and cyclophosphamide for patients with ALL: a phase II-study on behalf of the German Cooperative Transplant Study Group and ALL Study Group (GMALL)
- (2015) N Kröger et al. BONE MARROW TRANSPLANTATION
- Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL: for whom and when should interventions be tested?
- (2015) M A Pulsipher et al. BONE MARROW TRANSPLANTATION
- Stem-Cell Transplantation in Children With Acute Lymphoblastic Leukemia: A Prospective International Multicenter Trial Comparing Sibling Donors With Matched Unrelated Donors—The ALL-SCT-BFM-2003 Trial
- (2015) Christina Peters et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults
- (2015) Yvette L. Kasamon et al. JOURNAL OF CLINICAL ONCOLOGY
- Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study
- (2015) Elias Jabbour et al. LANCET ONCOLOGY
- Acute Lymphoblastic Leukemia in Children
- (2015) Stephen P. Hunger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treosulfan-based conditioning regimens for allogeneic HSCT in children with acute lymphoblastic leukaemia
- (2014) Heidrun Boztug et al. ANNALS OF HEMATOLOGY
- CMV promotes recipient T-cell immunity following reduced-intensity T-cell-depleted HSCT, significantly modulating chimerism status
- (2014) R. S. Sellar et al. BLOOD
- The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children’s Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial
- (2014) Michael A. Pulsipher et al. BLOOD
- Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study
- (2014) V. Conter et al. BLOOD
- Haploidentical hematopoietic SCT may be superior to conventional consolidation/maintenance chemotherapy as post-remission therapy for high-risk adult ALL
- (2014) Y-q Sun et al. BONE MARROW TRANSPLANTATION
- Allogeneic haematopoietic stem cell transplantation for infant acute lymphoblastic leukaemia with KMT2A (MLL) rearrangements: a retrospective study from the paediatric acute lymphoblastic leukaemia working group of the Japan Society for Haematopoietic Cel
- (2014) Motohiro Kato et al. BRITISH JOURNAL OF HAEMATOLOGY
- Follow-up of post-transplant minimal residual disease and chimerism in childhood lymphoblastic leukaemia: 90 d to react
- (2014) Cécile Pochon et al. BRITISH JOURNAL OF HAEMATOLOGY
- Clinical value of pre-transplant minimal residual disease in childhood lymphoblastic leukaemia: the results of the French minimal residual disease-guided protocol
- (2014) Virginie Gandemer et al. BRITISH JOURNAL OF HAEMATOLOGY
- HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry
- (2014) Loren Gragert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcome of transplantation for acute lymphoblastic leukemia in children with down syndrome
- (2014) Johann K. Hitzler et al. PEDIATRIC BLOOD & CANCER
- Comparable long-term outcomes after reduced-intensity conditioning versus myeloablative conditioning allogeneic stem cell transplantation for adult high-risk acute lymphoblastic leukemia in complete remission
- (2013) Ki-Seong Eom et al. AMERICAN JOURNAL OF HEMATOLOGY
- Fludarabine and Exposure-Targeted Busulfan Compares Favorably with Busulfan/Cyclophosphamide-Based Regimens in Pediatric Hematopoietic Cell Transplantation: Maintaining Efficacy with Less Toxicity
- (2013) I.H. Bartelink et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)
- (2013) J Tanaka et al. BONE MARROW TRANSPLANTATION
- Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donors
- (2013) D. I. Marks et al. HAEMATOLOGICA
- Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease
- (2013) V Bachanova et al. LEUKEMIA
- Unrelated Cord Blood Transplantation in Adult and Pediatric Acute Lymphoblastic Leukemia: Effect of Minimal Residual Disease on Relapse and Survival
- (2012) Veronika Bachanova et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Pediatric Acute Lymphoblastic Leukemia: Update of the 2005 Evidence-Based Review
- (2012) BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Transplantation Conditioning Regimens and Outcomes after Allogeneic Hematopoietic Cell Transplantation in Children and Adolescents with Acute Lymphoblastic Leukemia
- (2012) James Tracey et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia
- (2012) W. Leung et al. BLOOD
- Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies
- (2012) N. Gokbuget et al. BLOOD
- Quantification of minimal residual disease levels by flow cytometry at time of transplant predicts outcome after myeloablative allogeneic transplantation in ALL
- (2012) J Sanchez-Garcia et al. BONE MARROW TRANSPLANTATION
- Treosulphan-based radiation-free myeloablative conditioning for allogeneic transplant in infant acute lymphoblastic leukaemia
- (2012) Emma Corker et al. BRITISH JOURNAL OF HAEMATOLOGY
- Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia
- (2012) Yu Wang et al. CANCER
- High-dose etoposide in allogeneic stem cell transplantation
- (2012) Øystein Bruserud et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Outcomes after Induction Failure in Childhood Acute Lymphoblastic Leukemia
- (2012) Martin Schrappe et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcome of Myeloablative Conditioning and Unrelated Donor Hematopoietic Cell Transplantation for Childhood Acute Lymphoblastic Leukemia in Third Remission
- (2011) Eneida R. Nemecek et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- No difference in outcome between children and adolescents transplanted for acute lymphoblastic leukemia in second remission
- (2011) G. Dini et al. BLOOD
- Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation
- (2010) M. Mohty et al. BLOOD
- The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission
- (2010) D. I. Marks et al. BLOOD
- Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure
- (2010) Michel Duval et al. JOURNAL OF CLINICAL ONCOLOGY
- Analysis of the Role of Hematopoietic Stem-Cell Transplantation in Infants With Acute Lymphoblastic Leukemia in First Remission andMLLGene Rearrangements: A Report From the Children's Oncology Group
- (2010) ZoAnn E. Dreyer et al. JOURNAL OF CLINICAL ONCOLOGY
- Preemptive alloimmune intervention in high-risk pediatric acute lymphoblastic leukemia patients guided by minimal residual disease level before stem cell transplantation
- (2010) A C Lankester et al. LEUKEMIA
- Reduced-Intensity Conditioning followed by Peripheral Blood Stem Cell Transplantation for Adult Patients with High-Risk Acute Lymphoblastic Leukemia
- (2009) Anthony S. Stein et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 study
- (2009) B-S Cho et al. LEUKEMIA
- HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
- (2008) Leo Luznik et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Twenty Years of Unrelated Donor Bone Marrow Transplantation for Pediatric Acute Leukemia Facilitated by the National Marrow Donor Program
- (2008) Margaret L. MacMillan et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies
- (2008) J. Kurtzberg et al. BLOOD
- Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95
- (2008) A. Moricke et al. BLOOD
- Feasibility study of preemptive withdrawal of immunosuppression based on chimerism testing in children undergoing myeloablative allogeneic transplantation for hematologic malignancies
- (2008) B Horn et al. BONE MARROW TRANSPLANTATION
- ALLOGENEIC HEMOPOIETIC STEM CELL TRANSPLANTATION FOR CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA IN SECOND COMPLETE REMISSION—Similar Outcomes After Matched Related and Unrelated Donor Transplant: A Study of the Spanish Working Party for Blood and Marrow Transplantation in Children (Getmon)
- (2008) A. Muñoz et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now